CN Patent

CN102245173A — 醋酸乌利司他片剂

Assigned to Laboratoire HRA Pharma SAS · Expires 2011-11-16 · 15y expired

What this patent protects

本发明涉及用于口服给药的药物片剂，其包含醋酸乌利司他以及下述赋形剂：含量为50至98.5重量％的至少一种稀释剂，含量为0至10重量％的至少一种粘合剂，含量为0.5至10重量％的至少一种崩解剂，以及含量为0至10重量％的至少一种润滑剂。

USPTO Abstract

本发明涉及用于口服给药的药物片剂，其包含醋酸乌利司他以及下述赋形剂：含量为50至98.5重量％的至少一种稀释剂，含量为0至10重量％的至少一种粘合剂，含量为0.5至10重量％的至少一种崩解剂，以及含量为0至10重量％的至少一种润滑剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN102245173A
Jurisdiction
CN
Classification
—
Expires
2011-11-16
Drug substance claim
No
Drug product claim
No
Assignee
Laboratoire HRA Pharma SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.